By Allison Prang

 

AbbVie Inc. (ABBV) reported a profit, compared with a loss a year earlier, as its research and development costs fell by billions.

The company's profit was $2.8 billion, compared with a loss of $1.83 billion a year earlier. Earnings were $1.88 a share, compared with a loss of $1.23 a share.

Adjusted earnings were $2.21 a share, up from $1.90 a share. According to FactSet, analysts were expecting $2.19 a share.

Net revenue was $8.7 billion, up 4.8%. Analysts were expecting $8.69 billion.

The company's research and development costs sank to $1.54 billion. In the fourth quarter of 2018, they were $6.5 billion. AbbVie also reported $890 million in other operating income.

At the same time, the company reported $416 million in net other expense, compared with net other income of $393 million a year earlier. AbbVie also had $273 million in income tax expense compared with an income tax benefit of $547 million a year earlier.

 

Write to Allison Prang at allison.prang@wsj.com

 

(END) Dow Jones Newswires

February 07, 2020 08:24 ET (13:24 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more AbbVie Charts.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more AbbVie Charts.